Seer Inc.

SEER | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.86

$0 (0.00%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $102.54M

1D Range

1.86 1.89

52W Range

1.55 2.41

Valuation (TTM)

PE -1.52

PB 0.45

EV/EBITDA 0.43

Valuation (NTM)

Forward PE N/A

Forward PEG 0.37

Price Target $4

Cash Flow

FCF Yield -43.3%

SBC Adj. FCF Yield -53.6%

SBC Impact -23.9%

Margins

Gross Margin 46.3%

Operating Margin -511.4%

FCF Margin -319.4%

Growth (CAGR)

Revenue 3Y | 5Y -4.5% | 51.6%

Dil EPS 3Y | 5Y 2.3% | 2.3%

FCF 3Y | 5Y 8.8% | 8.8%

Returns

ROA -26.5%

ROE -27.2%

ROIC -28.6%

Financial Health

Net Cash

$152.85M

Current Ratio 14.74

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteo...

Sector Healthcare

Industry Biotechnology

Employees 124

IPO Date Dec 3, 2020

Website seer.bio

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞